A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25

Qiang Hu,Xue Zhang,Hongsong Peng,Jitian Guan,Zhangxin Huang,Bo Jiang,Dawei Sun

DOI: https://doi.org/10.1007/s10753-024-01991-x

2024-03-06

Inflammation

Abstract:Diabetic retinopathy (DR) is a diabetes-associated complication that poses a threat to vision, distinguished by persistent and mild inflammation of the retinal microvasculature. The activation of microglia plays a crucial role in driving this pathological progression. Previous investigations have demonstrated that ubiquitin-specific peptidase 25 (USP25), a deubiquitinating enzyme, is involved in the regulation of immune cell activity. Nevertheless, the precise mechanisms through which USP25 contributes to the development of DR remain incompletely elucidated. Firstly, we have demonstrated the potential mechanism by which ROCKs can facilitate microglial activation and augment the synthesis of inflammatory mediators through the modulation of NF-κB signaling pathways in a high-glucose milieu. Furthermore, our study has provided novel insights by demonstrating that the regulatory role of USP25 in the secretion of proinflammatory factors is mediated through the involvement of ROCK in modulating the expression of NF-κB and facilitating the nuclear translocation of the phosphatase NF-κB. This regulatory mechanism plays a crucial role in modulating the activation of microglial cells within a high-glycemic environment. Hence, USP25 emerges as a pivotal determinant for the inflammatory activation of microglial cells, and its inhibition exhibits a dual effect of promoting retinal neuron survival while suppressing the inflammatory response in the retina. In conclusion, the promotion of diabetic retinopathy (DR) progression by USP25 is attributed to its facilitation of microglial activation induced by high glucose levels, a process mediated by the ROCK pathway. These findings highlight the importance of considering USP25 as a potential therapeutic target for the management of diabetic neuroinflammation.

immunology,cell biology

What problem does this paper attempt to address?

The paper attempts to address the molecular mechanisms of neuroinflammation in diabetic retinopathy (DR), specifically how USP25 regulates microglial activation and inflammatory response through the ROCK/NF-κB signaling pathway in a hyperglycemic environment. Specifically, the study aims to explore the following points:

1. **Changes in USP25 expression in diabetic retinopathy**: By analyzing gene expression data from the GEO database, the study found that USP25 expression is significantly upregulated in diabetic retinal tissues.

2. **Effect of USP25 on microglial activation**: Through in vitro experiments (using HMC3 and BV2 cell lines) and in vivo experiments (using STZ-induced diabetic mouse models), the study found that increased expression of USP25 can promote microglial activation, thereby exacerbating retinal inflammatory response.

3. **Mechanism by which USP25 regulates inflammatory response through the ROCK/NF-κB signaling pathway**: The study found that USP25 regulates the expression of ROCK1 and ROCK2, further affecting the nuclear translocation and activation of NF-κB, thereby regulating the secretion of inflammatory factors.

4. **Effect of inhibiting USP25 on diabetic retinopathy**: By knocking down USP25 expression, the study found that it can alleviate diabetes-induced retinal inflammatory response and structural damage, improving the survival of retinal neurons.

In summary, the paper attempts to reveal the role of USP25 in diabetic retinopathy and provide a theoretical basis for its potential as a therapeutic target.